BamSEC and AlphaSense Join Forces
Learn More

Aerie Pharmaceuticals Inc

Formerly NASDAQ: AERI
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.3
from 10-Q 36 pages Nolan Financial Form Nonqualified Deferred Compensation Plan Adoption Agreement Nonqualified Deferred Compensation Plan
12/34/56
EX-10.2
from 10-Q 2 pages Agreement
12/34/56
EX-10.1
from 10-Q 18 pages Employment Agreement
12/34/56
EX-10.40
from 10-K 5 pages Aerie Pharmaceuticals, Inc. Amended & Restated Omnibus Incentive Plan Form of Restricted Stock Agreement
12/34/56
EX-10.39
from 10-K 3 pages Form of Incentive Stock Option Agreement
12/34/56
EX-10.38
from 10-K 6 pages Inducement Award Plan Form of Restricted Stock Agreement
12/34/56
EX-10.37
from 10-K 7 pages Form of Non-Qualified Stock Option Agreement
12/34/56
EX-10.36
from 10-K 24 pages Employment Agreement
12/34/56
EX-10.35
from 10-K 82 pages Collaboration and License Agreement by and Between Aerie Pharmaceuticals Ireland, Ltd. and Santen SA Dated as of December 6, 2021 Collaboration and License Agreement
12/34/56
EX-10.29
from 10-K 5 pages Third Amendment to Contract Manufacturing Supply Agreement
12/34/56
EX-10.1
from 10-Q 9 pages September 20, 2021 on Behalf of Aerie Pharmaceuticals, Inc. (The “Company”), This Letter Agreement Memorializes the Terms of Your Employment With the Company to Serve as Interim Executive Chair of the Board of Directors of the Company (The “Board”), Effective as of September 17, 2021 (The “Effective Date”)
12/34/56
EX-10.32
from 10-K 80 pages Collaboration and License Agreement by and Between Aerie Pharmaceuticals Ireland, Ltd. and Santen Pharmaceutical Co., Ltd. Dated as of October 28, 2020 Collaboration and License Agreement
12/34/56
EX-10.31
from 10-K 1 page First Amendment of the Aerie Pharmaceuticals, Inc. Second Amended & Restated Inducement Award Plan
12/34/56
EX-10.30
from 10-K ~5 pages Aerie Pharmaceuticals, Inc. Second Amended & Restated Omnibus Incentive Plan Form of Restricted Stock Unit Award Agreement
12/34/56
EX-10.23
from 10-K 15 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 35 pages Material contract
12/34/56
EX-10.1
from 8-K 35 pages Material contract
12/34/56
EX-10.2
from 8-K 47 pages Amended and Restated Guaranty and Security Agreement Dated as of May 2, 2018 by and Among Aerie Pharmaceuticals, Inc., a Delaware Corporation, as Borrower, the Other Grantors and Guarantors Party Hereto From Time to Time and Deerfield Private Design Fund III, L.P., as Agent for Itself and the Lenders Amended and Restated Guaranty and Security Agreement
12/34/56
EX-10.7
from 10-Q 29 pages Manufacture and Supply Agreement
12/34/56
EX-10.6
from 10-Q 4 pages Second Amendment to Contract Manufacturing Supply Agreement
12/34/56